<DOC>
	<DOCNO>NCT00816322</DOCNO>
	<brief_summary>The whole study divide two major part : ( A ) 12-week , double-blind , randomize control , parallel omega-3 fatty acid monotherapy study 60 patient mild moderate major depressive disorder . ( B ) The double-blind , randomize control , parallel omega-3 fatty acid add-on prevention study 60 patient major depressive disorder recovery status . The goal study examine therapeutic recurrence prevention effect omega-3 fatty acid major depressive disorder .</brief_summary>
	<brief_title>The Effect Fish Oil Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . DSMIV criterion major depressive disorder . 2 . Age age 1865 . 3 . Capacity willingness give write informed consent . 1 . Any major medical illness . 2 . A recent past history AxisI diagnose besides major depressive disorder , include psychotic disorder ; cognitively impair mental disorder ; impulse control disorder ; substance use disorder substance abuse ( last 6 month prior study ) ; primary anxiety disorder , include posttraumatic stress disorder panic disorder ; bipolar disorder ; AxisII diagnose , i.e . borderline antisocial personality disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>